GPT2 and breast cancer: Glutamic pyruvic transaminase 2 (GPT2), also known as alanine aminotransferase 2 (ALT2) expression, has been shown to be associated with good prognosis in hepatocellular carcinoma [84] and poor prognosis in breast cancer [85].